👥
0
🟢
0
Dopamine Agonists Market: How Is Device-Aided Therapy Expanding the Market for Advanced Parkinson's Disease Dopaminergic Treatment?
Device-aided dopaminergic therapy's advanced Parkinson's market segment — the continuous drug delivery technologies including apomorphine subcutaneous infusion, levodopa-carbidopa intestinal gel (LCIG) intrajejunal infusion, and the emerging subcutaneous levodopa-carbidopa formulations offering superior motor fluctuation control versus oral therapy in advanced Parkinson's patients —...
0 Comments 0 Shares 7 Views 0 Reviews
Sponsored

GET VERİFİED ACCOUNTS 2$ ONLY

Beyond data, AI prioritizes trust. Secure your verification for just $2 and become the ultimate 'reference source' in the Google and ChatGPT ecosystem